Asia-Pacific IVF Services Market Value to Grow $13,669 Mn by 2028 : Latest Report by Allied Market Research

In Vitro Fertilization (IVF) is a type of assisted reproductive technology in which eggs are artificially modified in the laboratory environment and then transplanted into the uterus. IVF is one of the most widely used treatments to help infertility problems, unwed mothers, and the LGBT community. Increased infertility rates, increased delay in pregnancy, a surge in IVF success rates, and increased disposable income in Asia Pacific are driving growth in the IVF services market. However, market growth is limited due to complications associated with IVF treatment and low awareness of IVF in some underdeveloped regions.

New report "Asia-Pacific IVF Services Market, by Cycle Type, and End User: Opportunity Analysis and Industry Forecast, 2018-2028", published by Allied Market Research. The market generated $2,527 million in 2014 and is projected to reach $13,669 million by 2028, growing at a CAGR of 12.4% from 2018 to 2028.

Based on cycle-type, the fresh cycle (non-donor) segment is major revenue contributor and is expected to dominate the market during the forecast period.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/853

Depending on end user, the Asia-Pacific IVF services market is dominated by the fertility clinics segment and is estimated to continue this trend during the forecast period, due to low cost of treatment and increase in number of fertility clinics.

Asia-Pacific IVF Services Market Segmentation

The Asia-Pacific IVF services market is segmented based on cycle type, end user, and country. Based on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.

Segment Review

The cycle type segment is further sub-segmented into fresh (non-donor) IVF cycles, thawed (non-donor) IVF cycles, and donor egg IVF cycles. The fresh IVF cycles (non-donor) is the largest segment, accounted for more than three-fifths of the total market in 2017. The fresh embryo IVF cycle begins with the ovarian stimulation, which is followed by retrieval of all eggs from the patient. These eggs are reinserted to create an embryo; these embryos are transferred back in the patient. Any remaining good quality embryos are frozen, which can be used in the future frozen IVF cycles.

Key Findings of the Asia-pacific IVF Services Market:

• Fresh IVF cycle (non-donor) segment is expected to grow at a significant CAGR of 12.9% (in terms of value) from 2018 to 2028
• Japan generated the highest revenue in the Asia-Pacific IVF services market in 2017 accounting for nearly half of the market share in 2017
• Japan witnessed the highest number of IVF treatments accounting for nearly two-fifths of the total cycles in 2017 and is expected to remain so throughout the forecast period
• India is expected to register the highest CAGR of 15.3% (in terms of value) throughout the forecast period

The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE - Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/853

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.